iScience (Apr 2022)

Phosphosite-dependent presentation of dual phosphorylated peptides by MHC class I molecules

  • Yingze Zhao,
  • Mingwei Sun,
  • Nan Zhang,
  • Xueyuan Liu,
  • Can Yue,
  • Lei Feng,
  • Shushen Ji,
  • Xiao Liu,
  • Jianxun Qi,
  • Catherine C.L. Wong,
  • George F. Gao,
  • William J. Liu

Journal volume & issue
Vol. 25, no. 4
p. 104013

Abstract

Read online

Summary: Phosphopeptides presented by major histocompatibility complex (MHC) class I have been regarded as a pivotal type of cancer neoantigens that are recognized by T cells. The structural basis of single-phosphorylated peptide presentation has been well studied. Diphosphorylation with one interval between two sites is one of the prevalent forms of multisite-phosphorylated peptides. Herein, we determined the molecular basis of presentation of two P4/P6 double pS-containing peptides by HLA-B27 and compared them with unmodified and single-phosphorylated peptide complexes. These data clarified not only the HLA allele-specific presentation of phosphopeptides by MHC class I molecules but also the cooperativity of peptide conformation within P4 and P6 phosphorylation sites. The phosphorylation of P6 site can influence the binding mode of P4 phosphorylated site to HLA-B27. And we found the diphospho-dependent attenuated effect of peptide binding affinity. This study provides insights into the MHC presentation features of diphosphopeptides, which is different from monophosphopeptides.

Keywords